• Nebyly nalezeny žádné výsledky

Pseudomonas & and other Non-fermenters

N/A
N/A
Protected

Academic year: 2022

Podíl "Pseudomonas & and other Non-fermenters"

Copied!
26
0
0

Načítání.... (zobrazit plný text nyní)

Fulltext

(1)

Pseudomonas & and other Non-fermenters

(2)

Are they pathogens or are they not?

• a complex mixture of opportunistic

pathogens widely in nature on organic substrates and colonizing plants,

animals and human.

• are ubiquitous organisms found in soil,

decaying organic matter, vegetation, and

water. Unfortunately, they are also found

throughout the hospital environment.

(3)

The group characterization

• small, gram-negative rods typically arranged in pairs, simple nutritional needs and quickly aquired

resistance to antibiotics they are common in hospital environment causing colonisation and, hence,

infections of hospitalized patient.

obligate aerobe; glucose oxidizer (enterobacteria

glucose fermenters); simple nutritional needs, ussually

oxidase positive (enterobacteria – negative)

(4)

Virulence (factors)

they are not very well characterized

virulence factorsstructural

components (e.g. capsule – suppresses neutrophil and lymphocyte activity, pili –

adhesin, LPS – endotoxin activity, ), toxin

& enzymes (e.g. exotoxins – tissue

destruction, hemolysins), ATB and

desinfectant resistance

(5)

Colonization and/or infection

• transiently colonize the respiratory and gastrointestinal tracts of hospitalized

patients, particularly those treated with broad-spectrum antibiotics

• most of the infections in humans are caused Pseudomonas aeruginosa,

Burkholderia cepacia, Stenotrophomonas

maltophilia, Acinetobacter baumannii

(6)

Treatment, prevention & control

• combined use of effective antibiotics (e.g., aminoglycoside and β-lactam

antibiotics); monotherapy is generally ineffective

preventing contamination of sterile

medical equipment and nosocomial

transmission; unnecessary use of broad- spectrum antibiotics can select for

resistant organisms

(7)

Species and infection

Pseudomonas aeruginosa

• pulmonary infections

• bacteremia

• primary skin infections

• urinary tract infections

• ear and eye infections

(8)

• many virulence factors Structural components

* adhesins – pili, nonpilus (binding to epith.cells)

* polysacharide capsule – alginate (anchor

bacteria to epit.cells, protect from phagocytosis and complement and antibiotics , biofilm in vivo)

* endotoxin (next slides)

* pyocyanin – blue pigment, toxic forms of oxygen (superoxide, hydrogen peroxide)– tissue

damage

Virulence factors of P. aeruginosa

(9)

Pseudomonas aeruginosa - the most significat pathogen are well known comparing to other non-fermenter species.

STRUCTURAL COMPONENTS: Pilli (fimbriae) and nonpilus adhesins bind to epithelial cells, similar in structure to the pilli found in N.

gonorrhoeae; capsule contain mucoid polysaccharide, adhesin,

inhibits antibiotic killing (e.g. aminoglycoside); suppresses neutrophil and lymphocyte activity; lipopolysaccharide – endotoxic activity;

pyocyanin – inhibit ciliary function; increases release of cytokines to mediate inflammation; mediates tissue damage through production of toxic oxygen radicals (e.g. hydrogen peroxide).

TOXINS & ENZYMES: exotoxin A - inhibits protein synthesis, produces tissue damage (e.g. skin, cornea); immunosuppressive; exotoxin S - inhibits protein synthesis; immunosuppression, cytotoxin (leukocidin) - cytotoxic for eukaryotic membranes (e.g., disrupts leukocyte

function, pulmonary microvascular injury), elastase - destruction of elastin-containing tissues (e.g., blood vessels, lung tissue, skin), collagen, immunoglobulins, and complement factors, phospholipase C - hemolysin; mediates tissue damage; stimulates inflammatory response, alkaline phosphatase - destruction of tissue

Virulence factors

(10)

Any tissue or organ may be affected with P. aeruginosa infections Localized infections: the infection follow trauma including also

medical instrumentation or stay in a risk area (e.g. swimming pools).

These infections may occur in the eye (e.g. keratitis, endophtalmitis), ear (e.g. necrotizing otitis externa), skin (wound sepsis), urinary and respiratory tract infections usually in hospitalized patients after

medical instrumentation (e.g. catheters), gastrointestinal infections – from mild diarrhea in children to necrotizing enterocolitis in

neutropenic cancer patients, central nervous infections – meningitis and brain abscesses usually associated with trauma or tumors. The localized infection coud lead to disseminated infection. Respiratory tract infections in patients with cystic fibrosis(CF) - P. aeruginosa is pathogen of chronic infection of patient with CF (as single infection or coinfection with Burkholderia cepacia complex) and chronic lung

diseases. Because the strains adapt to the changing environment during the infection usualy produce large mucoid polysaccharide (alginate) and biofilm in host or mucoid colonies on culture media.

Even susceptible strains to antibiotics which produce biofilm are usualy not susceptible to many of them.

Localized infections

(11)

Systemic infections

as bacteremia, endocarditis, bone and joint infections are sequale of spread of localized infection.

Infection caused by other non-fermenters e.g. Acinetobacter

baumannii, Stenotrophomonas maltophilia are significant agents of hospitally aquired infections.

(12)

ANTIBIOTIC RESISTANCE. P. aeruginosa is inherently resistant to many antibiotics and can mutate to even more resistant strains during therapy. P. aeruginosa produces a number of different β- lactamases that can inactivate many β-lactam antibiotics (e.g., penicillins, cephalosporins, carbapenems). Although numerous resistance mechanisms have been identified, the mutation of porin proteins constitutes the major mechanism of resistance.

Penetration of antibiotics into the pseudomonad cell is primarily through pores in the outer membrane. If the proteins forming the walls of these pores are altered to restrict flow into the cell,

resistance to many classes of antibiotics can develop simultaneously.

(13)

a) Specimens: pus, sputum, urine, blood, and other clinical material depending upon localization of the

process.

b) Microscopy: gram-negative rods usually in pairs.

c) Culture: because their simple nutritional need they grow well on basic culture media (nutrient agar), but because detection of some properties (e.g. hemolysis) enriched media (blood agar) are also used (fig.1). In case competetive flora appear in the samples a selective media are used.

Laboratory diagnosis

P. aeruginosa culture (nutrient agar) produced blue pigment (pyocyanin)

(14)

are focused on detection of specific biological properties of the agent (microscopy, bacterial colonies, enzymes detection, mass spectrum

Screening tests (preliminary identification): detection of some phenotypic properties are demonstrated in fig.

Identification

A B C

D

Fig. Pseudomonads and other (glucose) non-fermenters usually produce enzyme oxidase (A – blue color indicate production of the enzyme)

comparing to enterobacteriae (B, oxidase negative reaction) which are also gram-negative bacteria and produce similar bacterial colonies on culture media. Pseudomonads and other non-fermenters never ferment glucose (C), comparing with glucose feremntation in enterobacteria. The property is tested in semisolid medium containing glucose overlaid with mineral oil.

Maldi-TOF identification

(15)

Endotoxin is a lipopolysaccharide integrated in the outer membrane of Gram-negative bacteria

http://pathmicro.med.sc.edu/fox/lps.jpg

-Lipid A embedded in outer membrane, core and O antigen portions extending from the bacterial surface

(16)

Endotoxin properties

- Lipid A is toxic portion of endotoxin (activate complement and cytokines cascade)

- Exerts its effect only when bacteria lyse (result of complement atack, ingeston and killing by phagocytes or certain antibiotics)

- Lipid A become toxic if its in too high concentration

- Consequences – local inflamation (activation of complement) and systemic response (septic

shock)

(17)

• shock - clinical term, a set of events that lead to collapse of the circulatory system and can result in multiorgan system failure

• etiology - variety of insults but bacterial infection is the most common cause

• 1. step - production of cytokines by

monocytes, macrophages and other cells

• 2. step - activation of complement cascade

• 3. step – activation of coagulation cascade

Endotoxin and septic shock

(18)

Diagram of septic shock

(19)

• exotoxin A, S (blocking elongation factor inhibit proteosynthesis)

• Elastase (damage elastin in tissue - lung parenchymal damage, hemorragic lesions proteases – figures below, phospholipase C – tissue damase mediate and disrupting of inflamatory response

Toxin and enzymes

ecthyma granulosum

(20)

• resistant to most antibiotics

• monotherapy is not usually successful

• drug of first choice:

Aminoglycoside – AMG (gentamicin, tobramycin, amikacin, netilmicin – depending on local patterns of susceptibility)

and

Antipseudomonal penicillin (ticarcilin, piperacilin)

• Alternative drugs:

AMG+ CEF III (CTZ), + karbapenems (IMI,MER),+monobactams (AZT) fluorochinolones (CIP) + piperacillin, + CEF III (CTZ), + CEF IV cefepime

Treatment

(21)

• most significant – efflux mechanism – ATB are actively pumped from the bacterial cell (range of ATB –

TET,CHLORAMPH,QUINOLONES, β LACTAMS

• β lactamases – mostly located on chromosome (less on plasmids and transposons than in enterobacteria)

• resistance to carbapenemes – not linked to resistence to β lactamas but connected with lost of a porin (D2) – specific channel

• AMG – non-enzymatic (reduced OMP permeability, efllux pump – active transport need energy – ATP or proton

motif force)

• Quinolones – mutation in DNA gyrase, also efflux

Resistant determinants

(22)

Main types of bacterial drug efflux pumps

(23)

Genes encoding protein components of efflux

pumps

(24)

Acinetobacter baumannii – serious nosocomial pathogen of opportunistic infections (e.g. pulmonary)

Species and infection

(25)

Species and infection

Burkholderia cepacia Pulmonary infections: Range from

colonization to bronchopneumonia primary in patients with cystic fibrosis or chronic

granulomatous disease Opportunistic infections: Urinary tract

infections in catheterized patients; bacteria in immunocompromised patients with

contaminated intravascular catheters

(26)

Species and infection

Stenotrophomonas maltophilia Opportunistic infections: A variety of

infections (most commonly pulmonary and urinary tract) in immunocompromised

patients previously exposed to broad-

spectrum antimicrobial therapy

Odkazy

Související dokumenty

PASSINEAU MJ, GREEN EJ: Therapeutic effects of environmental enrichment on cognitive function and tissue integrity following severe traumatic brain injury in rats. Exp Neurol

prowazekii: Rash starts centrally at trunk and spreads toward extremities, usually spares head, palms and soles3.

The increase in phagocyte number and interleukin concentration in bronchoalvelolar fluid obtained from premature infants with chronic lung disease indicate that oxygen toxicity

Afferent arteriole responses to changes in renal perfusion pressure (RPP) and to P2X1 receptor activation in hypertensive rats. A: Renal autoregulation was assessed by

 fibromuscular interstitial connective tissue with smooth muscle cells and blood vessels.  prostatic glands with follicles/canals lined with simple

 Soft tissue techniques, according Lewit on skin, sub skin and fascia on lumbar area in cranial and caudal direction on the area of Th12-S1..  Isometric contraction of

Scare care By Lewit, using connective tissue fold, by pressing scar tissue with fingers forming a C and S shapes and wiat for release of the scar. Stretching connective tissues

• The structure and function of the body are based on the scientific studies of human biology (e.g., cells are the building blocks to tissues, organs, and body systems; blood